Heron Therapeutics Inc
NASDAQ:HRTX 4:00:00 PM EDT
| Market Cap (Intraday) | 398.55M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $2.79 |
| 50-Day MA | $2.73 |
| 200-Day MA | $1.76 |
Heron Therapeutics Inc Stock, NASDAQ:HRTX
4242 Campus Point Court, Suite 200, San Diego, California 92121
United States of America
Phone: +1.858.251.4400
Number of Employees: 126
Description
Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.